Long-term follow-up of participants in the first multicenter center HSCT trial for SCD identified that among male participants, none had elevated LH/FSH levels, but 4/13 evaluated patients (31%) had low levels LH/FSH (clinical significance unclear) and 10/13 (77%) had low testosterone levels [55]. This evidence concerns the gene BRD2 and Schnyder corneal dystrophy.